Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-01
1997-08-26
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530329, A61K 3808, C07K 706
Patent
active
056611277
ABSTRACT:
A peptide has been synthesized with the sequence ANVAENA (SEQ ID NO:1). This peptide, designated "cytomodulin," is able to mimic a broad range of activities of TGF-.beta.1 in various cell types. Compositions for applications such as tissue repair are provided that comprise a biocompatible matrix having cytomodulin admixed with or carried by the matrix.
REFERENCES:
patent: 5002583 (1991-03-01), Pitaru et al.
patent: 5055447 (1991-10-01), Palladino et al.
patent: 5158934 (1992-10-01), Ammann et al.
patent: 5171574 (1992-12-01), Kuberasampath et al.
patent: 5178845 (1993-01-01), Constantz et al.
patent: 5208219 (1993-05-01), Ogawa et al.
patent: 5236905 (1993-08-01), Brankovan et al.
patent: 5240912 (1993-08-01), Todaro
patent: 5258029 (1993-11-01), Chu et al.
patent: 5268455 (1993-12-01), Cianciolo
patent: 5270300 (1993-12-01), Hunziker
patent: 5284763 (1994-02-01), Derynk et al.
patent: 5322933 (1994-06-01), Davies et al.
patent: 5324519 (1994-06-01), Dunn et al.
patent: 5364839 (1994-11-01), Gerhart et al.
patent: 5368858 (1994-11-01), Hunziker
Archer et al., "Transforming Growth Factor .beta.1: Secondary Structure as Determined by Heteronuclear Magnetic Resonance Spectroscopy," Biochemistry, 32, (1993), pp. 1164-1171.
Basler et al., "Control of Cell Pattern in the Neural Tube: Regulation of Cell Differentiation by dorsalin-1, a Novel TGF.beta. Family Member," Cell, 73, (May 21, 1993), pp. 687-702.
Berge et al., "Pharmaceutical Salts," Journal of Pharmaceutical Sciences, 66:1, (Jan. 1977), pp. 1-19.
Bone et al., "Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis," Chest, 101:6 (Jun. 1992), pp. 1644-1655.
Daopin et al., "Crystal Structure of TGF-.beta.2 Refined at 1.8 .ANG. Resolution," Proteins, 17, (1993), pp. 176-192.
Hubbell and Langer, "Tissue Engineering," Chemical and Engineering News, (Mar. 13, 1995), pp. 42-54.
Massague, "The Transforming Growth Factor-.beta. Family," Annu. Rev. Cell Biol., 6, (1990), pp. 597-641.
Termine and Posner, "Calcium Phosphate Formation in vitro: I. Factors Affecting Initial Phase Separation," Archives of Biochemistry and Biophysics, 140, (1970), pp. 307-317.
Termine et al., "Calcium Phosphate Formation in vitro: II. Effects of Environment of Amorphous-Crystalline Transformation," Archives of Biochemistry and Biophysics, 140, (1970), pp. 318-325.
Amatayakul-Chantler et al., "[Ser.sup.77 ] Transforming Growth Factor-.beta.1," Journal of Biological Chemistry, 269:44, (1994), pp. 27687-27691.
Chang et al., "Cartilage-derived Morphogenetic Proteins," Journal of Biological Chemistry, 269:45, (1994), pp. 28227-28234.
Chopra et al., "Newly Synthesized Proteoglycans Secreted by Sequentially Derived Populations of Cells from New-Born Rat Calvaria," Cell Differentiation and Development, 32, (1990), pp. 47-59.
Colletta et al., "The Growth Inhibition of Human Breast Cancer Cells by a Novel Synthetic Progestin Involves the induction fo Transforming Growth Factor Beta," J. Clin. Invest., 87, (1991), pp. 277-283.
Galera et al., "Effect of Transforming Growth Factor-.beta.-1 (TGF-.beta.1) on Matrix Synthesis by Monolayer Cultures of Rabbit Articular Chondrocytes during . . . ," Experimental Cell Research, 200 (1992), pp. 379-392.
Grande et al., "Transforming Growth Factor-.beta.1 Induces Collagen IV Gene Expression in NIH-3T3 Cells," Laboratory Investigation, 69:4, (1993), pp. 387-395.
Gunther et al., "Transforming Growth Factor .beta.1 Regulates Tissue Inhibitor of Metalloproteinases-1 Expression in Differentiated Human Articular Chondrocytes," Arthritis & Rheumatism, 37;3, (1994), pp. 395-405.
Hamilton and Millis, "Developmental Roles for Growth Factor-Regulated Secreted Proteins," Current Topics in Development Biology, 24, (1990), pp. 193-218.
Li and Drucker, "Growth Facator-like Properties of Parathyroid Hormone-related Peptide in Transfected Rodent Cell Lines," Cancer Research, 53, (1993), pp. 2980-2986.
Lynch and Giannobile, "Polypeptide Growth Factors: Molecular Mediator of Tissue Repair," Chapter 33 in Molecular Pathogenesis of Periodontal Disease, (1994), pp. 415-425.
Massague et al., "Multiple Type-.beta. Transforming Growth Factors and Their Receptors," Journal of Cellular Physiology Supplement, 5, (1987), pp. 43-47.
Matrisian and Hogan, "Growth Factor-Regulated Proteases and Extracellular Matrix Remodeling during Mammalian Development," Current Topics in Developmental Biology, 24, (1990), pp. 219-259.
Nakanishi et al., "Expression of Nerve Growth Factor Family Neurotrophins in a Mouse Osteoblastic Cell Line," Biochemical and Biophysical Research Communications, 198:3, (1994), pp. 891-897.
Nogami et al., "Bioassay of Chondrocyte Differentiation by Bone Morphogenetic Protein," Clinical Orthopaedics and Related Research, 258, (1990), pp. 295-299.
O'Reilly et al., "Regulation of Expression of Transforming Growth Factor-.beta.2 by Transforming Growth Factor-.beta. Isoforms is Dependent upon Cell Type," Growth Factors, 6, (1992), pp. 193-201.
Rosen et al., "Bone Induction and Transforming Growth Factor-.beta.," Annals New York Academy of Sciences, pp. 98-106 (1992).
Rutherford et al., "Induction of Reparative Dentine Formation in Monkeys by Recombinant Human Osteogenic Protein-1," Archs oral Biol., 38:7, (1993), pp. 571-576.
Sampath et al., "Recombinant Human Osteogenic Protein-1 (hOP-1) Induces New Bone Formation in Vivo with a Specific Activity Comparable with . . . " Journal of Biological Chemistry, 267:28, (1992), pp. 20352-20362.
Saunders and D'Amore, "FGF and TFG-.beta.: Actions and Interactions in Biolgoical Systems," Critical Reviews in Eukaryotic Gene Expression, 1:3, (1991), pp. 157-172.
Schwarz et al., "Aberrant TGF-.beta. Production and Regulation in Metastatic Malignancy," Growth Factors, 3, (1990), pp. 115-127.
Segarini, Patricia R., "Cell Type Specificity of TGF-.beta. Binding," Annals New York Academy of Sciences, pp. 73-89 (1990).
Sporn et al., "Some Recent Advances in the Chemistry and Biology of Transforming Growth Factor-Beta," Journal of Cell Biology, 105, (1987), pp. 1039-1045.
Taketazu et al., "Enhanced Expression of Transforming Growth Factor-.beta.s and Transforming Growth Factor-.beta. Type II Receptors . . . ," Laboratory Investigation, 70:5, (1994), pp. 620-630.
van Beuningen et al., "Transforming Growth Facator-.beta.1 Stimulates Articular Chondrocyte Proteoglycan Synthesis and Induces Osteophyte Formation . . . ," Laboratory Investigation, 71:2, (1994), pp. 279-290.
Wozney et al., "Novel Regulators of Bone Formation: Molecular Clones and Activities," Science, 242, (1988), pp. 1528-1534.
Joyce et al., "Role of Transforming Growth Factor-.beta. in Fracture Repair," Annals New York Academy of Sciences, pp. 105-123 (1990).
Bhatnagar Rajendra S.
Qian Jing Jing
Gupta Anish
The Regents of the University of California
Tsang Cecilia J.
LandOfFree
Peptide compositions with growth factor-like activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide compositions with growth factor-like activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide compositions with growth factor-like activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988579